Ensign Peak Advisors’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,900
Closed -$296K 1776
2023
Q1
$296K Buy
8,900
+2,600
+41% +$99.8K ﹤0.01% 1714
2022
Q4
$193K Buy
6,300
+450
+8% +$14.2K ﹤0.01% 1747
2022
Q3
$200K Buy
5,850
+400
+7% +$17.1K ﹤0.01% 1876
2022
Q2
$189K Hold
5,450
﹤0.01% 1810
2022
Q1
$240K Hold
5,450
﹤0.01% 1826
2021
Q4
$343K Hold
5,450
﹤0.01% 1765
2021
Q3
$574K Hold
5,450
﹤0.01% 1595
2021
Q2
$965K Buy
5,450
+750
+16% +$121K ﹤0.01% 1449
2021
Q1
$627K Buy
4,700
+3,500
+292% +$542K ﹤0.01% 1560
2020
Q4
$162K Buy
+1,200
New +$122K ﹤0.01% 1741

Other funds holding ZLAB

Ensign Peak Advisors's ZLAB Position: Q2 2023 in Review

Ensign Peak Advisors sold out of Zai Lab (ZLAB) in Q2 2023, closing a stake of 8,900 shares — an estimated $296K sold.

Ensign Peak Advisors first reported a position in ZLAB in Q4 2020 and held it in 10 quarters. The position peaked at $965K in Q2 2021. 137 funds tracked by Wall St. Rank hold ZLAB as of Q2 2023.

  • Ensign Peak Advisors reported no remaining Zai Lab position as of Q2 2023 after selling out during the quarter.
  • Ensign Peak Advisors sold 8,900 Zai Lab shares in Q2 2023, an estimated $296K.
  • Ensign Peak Advisors first reported a position in Zai Lab in Q4 2020 and held it in 10 quarters.
  • Ensign Peak Advisors's Zai Lab position peaked at $965K in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Zai Lab as of Q2 2023.

Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.